GLSI

GLSI

USD

Greenwich LifeSciences Inc. Common Stock

$8.090-0.620 (-7.118%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$8.710

Máximo

$9.100

Mínimo

$8.020

Volumen

0.08M

Fundamentos de la Empresa

Capitalización de Mercado

110.3M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.07M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $8.02Actual $8.090Máximo $15.47

Noticias Relacionadas

GlobeNewswire

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial

STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01,

Ver más
Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial
GlobeNewswire

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial

STAFFORD, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01,

Ver más
Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial